Eritema necrolítico migratorio no asociado a glucagonoma

Actas Dermo-Sifiliograficas

Volumn 88, Issue 10, 1997, Pages 536-541

  Sabaris, M Del Carmen Fariña ^a,b   Casimiro, C ^a   Soriano, M L ^a   Grilli, R ^a   Escalonilla, P ^a   Martin L ^a   Requena, L ^a   Domine, M ^a   Barat, A ^a   De Castro, A ^a  

^a Clinica Ntra   (Spain)

^b Ayuntamiento de Madrid   (Spain)

Author keywords

5 fluorouracil; Glucagonoma; Hepatic disease; Necrolytic migratory erythema

Indexed keywords

EID: 2342514261     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Thivolet J, Perrot H, Hermier C et al. Erytheme cutané migrateur avec necrose epidermique superficielle au cours d'une pancrealite chronique. Ann Dermatol Syph 1974;101;415-7.
2. Goodenberger DM, Lawley TJ, Strower W et al. Necrolytic migratory erythema without glucagonoma: report of two cases. Arch Dermatol 1979;115:1429-32.
3. Doyle JA, Schroeter AL, Rogers RS. Hyperglucagonemia and necrolytic migratorv erythema in cirrhosis: possible pseudoglucagonoma syndrome. Br J Dermatol 1979;10:581-7.
4. Franchimont C, Pierard G, Leeyck AS et al. Angioplastic necrolytic migratory erythema: unique association of necrolytic migratory erythema, extensive angioplasia and high molecular weight glucagon-like polypeptide. Am J Dermatopathol 1982;4:485-85.
5. Walker NPJ. Atypical necrolytic migratory erythema, in association with a jejunal adenocarcinoma. J R Soc Med 1982;75:134-5.
6. Ranchoff RE, Kantor GR, Slugg PH et al. Necrolytic migratory erythema-like dermatitis with malabsorption. Clev Clin Q 1985;52:81-5.
7. Mass MC, Carlson R. Necrolytic migratory erythema associated with odontogenic infection: an example of pseudoglucagonoma syndrome. Cutis 1988;41:190-2.
8. Kelly CP, Johnston CF, Nolan N et al. Necrolytic migratory erythema with elevated plasma enteroglucagon in celiac disease. Gastroenterology 1989;96:1350-3.
9. Blackford S, Wright S, Roberts DL. Necrolytic migratory erythema without glucagonoma: the role of dietary essential fatty acids. Br J Dermatol 1991;125:460-2.
10. Kasper CS, McMurry K. Necrolytic migratory erythema versus canine superficial necrolytic dermatitis. Is hepatic impairment a clue to pathogenesis? J Am Acad Dermatol 1991;25:534-41.
11. Masri-Fridling GD, Turner MLC. Necrolytic migratory erythema without glucagonoma (letter). J Am Acad Dermatol 1992;27:486.
12. Kerleau JM, Levesque H, Cailleux N, Cancel A, Boullie MC, Courtois H. Deficit isole on zinc et erytheme necrolytique migrateur. A propos d'une observation. Rev Med Interne 1993; 14:784-7.
13. Thorisdottir K, Camisa C, Tomecki KJ, Bergfeld WT. Necrolytic migratory erythema: a report of three cases. J Am Acad Dermatol 1994;30:324-9.
14. Bencini PL, Vigo GP, Caputo R. Necrolytic migratory erythema without glucagonoma in a heroin-dependent patient. Dermatology 1994;189:72-4.
15. Tanner M, Brasch J, Cristophers E. Erythema necroticans migrans ohne glukagonom. Hautarzt 1994;45:480-3.
16. Marinckovich MP, Botella R, Datloff J, Sangueza OP. Necrolytic migratory erythema without glucagonoma in patients with liver disease. J Am Acad Dermatol 1995;32:604-9.
17. Ossowski B, baum C. Das pseudoglukagonom-syndrom. Fallbericht, therapeutische, moglichkeiten unad hypothesen zur atiologie. Hautarzt 1995;46:173-6.
18. Maillard H, Célérier P, Maisonnenve C, Forest JL, Bland A, Pasquiou C. Erythéme nécrolytique migrateur sans glucagonome. Ann Dermatol Venereol 1995;122:786-8.
19. Wynick D, Hammond P, Bloom S. The glucagonoma syndrome. Clin Dermatol 1993;11:93-7.
20. Wermersa RA, Fatourechi V, Wynne AG, Kvols LK, Lloyd RV, The glucagonoma Syndrome. Medicine 1996;75.53-63.
21. Becker SW, Kahan D, Rothman S. Cutaneous manifestations of internal malignant tumours. Arch Dermatol Syph 1942;45:1069-80.
22. Wilkinson DS. Necrolytic migratory erythema with carcinoma of the pancreas. Trans St Johns Hosp Dermatol Soc 1973;59:244-50.
23. El Darouti M, El Ela MA. Acral necrolytic erythema: a sign of hepatitis C infection. In J Dermatol 1996;35:252-6.
24. Black CK, Piette WW. The multisyndrome spectrum of necrolytic migratory erythema. Current Opinion In Dermatol, second edition. Dahl MV, Lynch PJ, eds. Current Science, Philadelphia 1995, págs 87-93.
25. Mehregan DA, Mehregan DR. Paraneoplastic syndromes. Adv Dermatol 1994:9:25-43.
26. Poole S, Fenske A. Cutaneous markers of internal malignancy II. Paraneoplastic dermatoses and environmental carcinogens. J Am Acad Dermatol 1993;28:174-64.
27. Ackerman AB. Histological diagnosis of inflamatory skin disease. Lea and Febiger, Philadelphia 1988. Pág. 512.
28. Hunt SJ, Narus VT, Abell E. Necrolytic migratory erythema: diskeratotic dermatitis, a clue to early diagnosis. J Am Acad Dermatol 1991;24:473-7.
29. Peterson LL, Shaw JC, Acott KM et al. Glucagonoma syndrome: in vitro evidence that glucagon increases epidermal arachidonic acid. J Am Acad Dermatol 1984;11:468-73.
30. Gan-Elpano M, Aeberhard E, Mead JF. On the mechanisms of fatty acid transformations in membranes. Lipids 1981;16:790-5.
31. Jenkins DK, Mitchell JC, Manku MS et al. Effects of albumin on fatty acid, protein and eicosanoid levels in rat mesenteric arterial bed perfusions. Can J Physiol Pharmacol 1988:66:679-82.
32. Stevens HP, Ostlere LS, Begent RH, Dooley JS, Rustin MH. Pellagra secondary to 5-fluorouracil. Br J Dermatol 1993;128:578-80.
33. Miller SJ. Nutritional deficiency and the skin. J Am Acad Dermatol 1989,21:1-30.